Eye Scans as Markers of Progression in Multiple Sclerosis
Studies retinal scans and vessel tests in adults with multiple sclerosis and healthy controls.
Plain-language title generated from the registry record
Registry title: REtinal Markers In Neuroinflammatory Diseases ("REMIND")
Key facts
- Where
- Basel, SwitzerlandSee the site
Where in Switzerland
- University Hospital Basel, Department of NeurologyBasel, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Basel, Switzerland
- Trial code
- NCT06369766
- Record updated
- 23 May 2025
- Original description
The goal of this observational study, including patients with Multiple Sclerosis, patients with other neuroinflammatory diseases and healthy controls, is to determine the predictive value of retinal markers in predicting disease progression. Participants complete a questionnaire and undergo various non-invasive retinal routine clinical examinations.Read full original descriptionShow less
Retinal Markers in Neuroinflammatory Diseases: a Prospective Observational Study
The goal of this observational study, including patients with Multiple Sclerosis, patients with other neuroinflammatory diseases and healthy controls, is to determine the predictive value of retinal markers in predicting disease progression. Participants complete a questionnaire and undergo various non-invasive retinal routine clinical examinations.
Inclusion: All groups:; Age >18 years old; Patients with Multiple Sclerosis:; Diagnosis of Multiple Sclerosis, according to the last revisions of the McDonald Criteria (2017); Patients with other neuroinflammatory diseases:; Diagnosis of Neuromyelitis optica spectrum disorder or Myelin oligodendrocyte glycoprotein antibody disease or other neuroinflammatory disorders other than Multiple Sclerosis.
Exclusion: All groups:; Inability to undergo Optical Coherence Tomography (OCT) and/or retinal vessel imaging (e.g. severe nystagmus that prevents eye fixation on both eyes); Presence of any ocular pathology that may interfere with the validity of the OCT/retinal vessel analysis (cataracts, glaucoma, history of refractive defects >6 D etc.); Pregnancy and Lactation; Healthy Controls; History of other neurological conditions: participants with a history of other significant neurological conditions that might interfere with the assessment or interpretation of the signs and symptoms will be excluded (e.g. confirmed Stroke, Acute disseminated encephalomyelitis, Chronic inflammatory Demyelinating Disease, Polyneuropathy, etc.).